Marie‐Thérése Stockhausen

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen et al. · Neuro-Oncology · 2010 · 227 citations · Full text

Activation of the EGFR Gene Target EphA2 Inhibits Epidermal Growth Factor–Induced Cancer Cell Motility

Alice Bjerregaard Larsen, Mikkel W. Pedersen, Marie‐Thérése Stockhausen et al. · Molecular Cancer Research · 2007 · 136 citations

Regulation of the Notch target gene Hes-1 by TGFα induced Ras/MAPK signaling in human neuroblastoma cells

Marie‐Thérése Stockhausen, Jonas Sjölund, Håkan Axelson · Experimental Cell Research · 2005 · 96 citations

Developmental Biology, Signal Transduction, Signaling Pathway +6

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

Signe Regner Michaelsen, Ib Jarle Christensen, Kirsten Grunnet et al. · BMC Cancer · 2013 · 86 citations · Full text

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance

Signe Regner Michaelsen, Mikkel Staberg, Henriette Pedersen et al. · Neuro-Oncology · 2018 · 86 citations · Full text